Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.
King BA, Mesinkovska NA, Craiglow B, Kindred C, Ko J, McMichael A, Shapiro J, Goh C, Mirmirani P, Tosti A, Hordinsky M, Huang KP, Castelo-Soccio L, Bergfeld W, Paller AS, Mackay-Wiggan J, Glashofer M, Aguh C, Piliang M, Yazdan P, Lo Sicco K, Cassella JV, Koenigsberg J, Ahluwalia G, Ghorayeb E, Fakharzadeh S, Napatalung L, Gandhi K, DeLozier AM, Nunes FP, Senna MM. King BA, et al. Among authors: fakharzadeh s. J Am Acad Dermatol. 2022 Feb;86(2):359-364. doi: 10.1016/j.jaad.2021.08.043. Epub 2021 Aug 30. J Am Acad Dermatol. 2022. PMID: 34474079 Free article.
The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus.
Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S, Kantor J, Kim E, Militello G, McGinnis K, Richardson S, Treat J, Vittorio C, Van Voorhees A, Werth VP. Albrecht J, et al. Among authors: fakharzadeh s. J Invest Dermatol. 2005 Nov;125(5):889-94. doi: 10.1111/j.0022-202X.2005.23889.x. J Invest Dermatol. 2005. PMID: 16297185 Free PMC article.
Reliability and convergent validity of two outcome instruments for pemphigus.
Rosenbach M, Murrell DF, Bystryn JC, Dulay S, Dick S, Fakharzadeh S, Hall R, Korman NJ, Lin J, Okawa J, Pandya AG, Payne AS, Rose M, Rubenstein D, Woodley D, Vittorio C, Werth BB, Williams EA, Taylor L, Troxel AB, Werth VP. Rosenbach M, et al. Among authors: fakharzadeh s. J Invest Dermatol. 2009 Oct;129(10):2404-10. doi: 10.1038/jid.2009.72. Epub 2009 Apr 9. J Invest Dermatol. 2009. PMID: 19357707 Free PMC article.
Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]).
Strober BE, Bissonnette R, Fiorentino D, Kimball AB, Naldi L, Shear NH, Goyal K, Fakharzadeh S, Calabro S, Langholff W, You Y, Galindo C, Lee S, Lebwohl MG. Strober BE, et al. Among authors: fakharzadeh s. J Am Acad Dermatol. 2016 May;74(5):851-61.e4. doi: 10.1016/j.jaad.2015.12.017. Epub 2016 Feb 4. J Am Acad Dermatol. 2016. PMID: 26853180 Free article.
Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Strober B, Gooderham M, de Jong EMGJ, Kimball AB, Langley RG, Lakdawala N, Goyal K, Lawson F, Langholff W, Hopkins L, Fakharzadeh S, Srivastava B, Menter A. Strober B, et al. Among authors: fakharzadeh s. J Am Acad Dermatol. 2018 Jan;78(1):70-80. doi: 10.1016/j.jaad.2017.08.051. Epub 2017 Nov 6. J Am Acad Dermatol. 2018. PMID: 29102053 Free article.
Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials.
Gordon KB, Papp KA, Langley RG, Ho V, Kimball AB, Guzzo C, Yeilding N, Szapary PO, Fakharzadeh S, Li S, Hsu MC, Reich K. Gordon KB, et al. Among authors: fakharzadeh s. J Am Acad Dermatol. 2012 May;66(5):742-51. doi: 10.1016/j.jaad.2011.06.041. Epub 2011 Oct 5. J Am Acad Dermatol. 2012. PMID: 21978572 Clinical Trial.
Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM.
Goreshi R, Okawa J, Rose M, Feng R, Lee LA, Hansen CB, Bangert CA, Connolly MK, Davis MD, Callen JP, Fett NM, Fakharzadeh SS, Clarke JT, Werth VP. Goreshi R, et al. Among authors: fakharzadeh ss. J Invest Dermatol. 2012 Apr;132(4):1117-24. doi: 10.1038/jid.2011.440. Epub 2012 Jan 5. J Invest Dermatol. 2012. PMID: 22217740 Free PMC article.
WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR]).
Papp K, Gottlieb AB, Naldi L, Pariser D, Ho V, Goyal K, Fakharzadeh S, Chevrier M, Calabro S, Langholff W, Krueger G. Papp K, et al. Among authors: fakharzadeh s. J Am Acad Dermatol. 2015 Jan 9:S0190-9622(14)02102-1. doi: 10.1016/j.jaad.2014.10.025. Online ahead of print. J Am Acad Dermatol. 2015. PMID: 25582533
74 results